In the three pancreatic cancer cell lines (BxPC3, AsPC-1 and CFPAC), most BiXAbTM inhibited AKT phosphorylation, except 2Trastu-1Cetu-Fc and 2Trastu-1Matu-Fc (and the structural isomers). The gene discussed is AKT1; the disease is pancreatic neoplasm.